OXFD News and Press, Oxford Immunotec Global PLC From 01/14/21

OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, announces the launch of 100 Physicians Find , a monthly survey that takes the pulse of on...

Oxford Immunotec ([[OXFD]] -1.0%) has collaborated with Valneva, wherein, the company will perform T cell testing on participants receiving Valneva's inactivated whole-virus COVID-19 vaccine candidate (VLA2001) with the research use only T-SPOT Discovery SARS-CoV-2 test.The VLA2001-201 study ...

OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, announce the start of a collaboration with Valneva. The Company will perform T cell testing o...

Merger activity increased significantly last week with eight new deals announced. The acquisition of Alaska Communications Systems Group by ATN International. The acquisition of FLIR Systems by Teledyne Technologies Incorporated. For further details see: Merger...

SOS Limited (SOS) +66%.Future FinTech Group (FTFT) +32% after CCPC accepted the Company's application for ten software copyrights.CBAK Energy Technology (CBAT) +39%.The9 Limited (NCTY) +35%.Xunlei Limited (XNET) +31%.Oxford Immunotec Global PLC (OXFD) +27% as PerkinElmer to acquire ...

PerkinElmer to acquire Oxford Immunotec for USD 22.00 per share in cash Transaction expected to be completed in the first half of 2021 PerkinElmer, Inc. (NYSE: PKI) (“ PerkinElmer ”) and Oxford Immunotec Global PLC (NASDAQ: OXFD) (" Oxford Imm...

Noting that its stock does not adequately reflect the strength of the core business outlook, Oxford Immunotec (OXFD) announces the allocation of $40 – 80M for share buybacks over the next two-to-three-year period, up from ~$12M over the last twelve-month period. The...

OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, announce the formation and initial meeting of the Global T cell expert consortium (GTEC). The...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

The South Korean regulatory authority has approved Oxford Immunotec's ([[OXFD]] +1.3%) T-Cell Select reagent kit, an immune cell separation reagent used to automate the preparation of the cells required to run the Company’s T-SPOT.TB test, for diagnosis of TB i...